$CTAS · Cintas Corporation
Latest call · 2026-09-22
The call
Head-to-head · Claude vs the Street vs reality
| Claude | Street | Actual | |
|---|---|---|---|
| EPS | $1.40 | $1.36 | ⏳ pending |
| Revenue | $2.99B | $2.98B | — |
| Direction (1d) | 🟢 UP |
🟢 UP
7B · 5H · 1S
|
— |
| 1d move | +1.2% | — | — |
| 3d move | +1.8% | — | — |
Thesis
Cintas prints its 5th straight beat with $1.40 EPS on $2.99B revenue — 3% ahead of the Street on the bottom line, in-line on the top. Route Advisor ML routing (60% North American footprint) and First Aid margin ramp are the two under-modeled operating tailwinds Street misses. Setup is hype_neutral: 32x fwd P/E, 3.4% short float, priced for a routine beat, not a raise.
What would flip it
The classic Cintas Q1 sandbag guide — if FY27 initial range midpoint undercuts the FY26 exit run-rate, headline beat gets faded and stock could give back 2-3% intraday.
The market's narrative
Street sees a routine 4th-consecutive Cintas beat of ~1-2% on the print with an FY27 guide reaffirm; low-vol high-quality compounder trading at 32x fwd P/E — priced for perfection but not fragile.
Where the Street may be wrong
- Route Advisor (ML route optimization) is now live across ~60% of the North American footprint by end-FY26 — should compound gross margin +30-50bps through FY27 and is not in the consensus opex line item.
- First Aid & Safety segment op margin inflection from 11% (FY24) → 13% (FY25) → ~15% (FY26 guided) — continuation of that trajectory drops straight through to EPS and is under-modeled by generalist analysts who lump it into 'other services'.
- Paychex Q1 print (same fiscal calendar) beat and guided in-line last week — read-through to SMB payroll base is directly the CTAS uniform rental client demand signal, and it's positive.
Peer read: UNF (Unifirst) July beat with cautious pipeline commentary (mildly negative for facility-services demand); PAYX Q1 last week clean beat + in-line guide (positive read for SMB employment base driving CTAS uniform seats). CTAS is the higher-quality operator so peer-reads de-weighted vs company-specific execution.
Reasoning
- Consensus $1.36 EPS on $2.98B revenue implies +13% EPS / +9.5% Rev YoY. Cintas has beat 4 straight quarters by ~1.8% average — baseline print is $1.385 before adding tailwinds.
- Route Advisor rollout + First Aid margin ramp + FY26 exit-rate tailwinds get me to $1.40 EPS (+2.9% vs consensus, exactly at whisper $1.40). Revenue $2.99B (+0.3% — no meaningful top-line gap vs Street).
- Technicals: RSI 72.9 on daily (overbought), MACD histogram barely positive (+0.07 — momentum decelerating). EMA200 at $197.46 vs spot $199.45 — trading right at the multi-month reversion zone. Not a tape screaming for a squeeze; more like a coiled compounder into a beat.
- Hype gauge: short float 3.4% (unwashed), analyst rating 2.27 (Buy-lean), Zacks Rank 2, Earnings ESP +3.60%, BofA upgrade to Buy last month, PT $217.73 (~9% upside). Positioning is constructive but not extreme — hype_neutral leaning slightly hype_high given RSI + priced-in beat streak.
- Beat + FY27 initial guide (Cintas always sandbags Q1 = conservative) → modest UP but sell-the-news risk if guide undershoots FY26 exit rate. Rule-of-thumb bookend: hype_neutral + beat → moderate UP (+1-2% 1d).
Risks to the call
- FY27 initial guide sandbag: if mgmt prints a guide range whose midpoint is below the FY26 4Q run-rate, stock -2 to -3% regardless of headline beat (this is the single biggest downside vector).
- RSI 72.9 into print is textbook 'good news already in the tape' setup — a mere in-line print with no incremental guide raise could trigger -1 to -1.5% mean-revert to the 50-day.